Lidokain-Fluorescein Bausch & Lomb

Fluorescein Sodium and Lidocaine Hydrochloride, the active ingredients in Lidokain-Fluorescein, are local anesthetic and ophthalmic diagnostic agents presented as an ophthalmic solution for ocular use. They provide topical anesthesia and allow visualization of corneal defects in patients undergoing minor eye examinations or procedures.

GNH USA supplies Lidokain-Fluorescein as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidokain-Fluorescein is used in ophthalmology for diagnostic staining and temporary anesthesia of the ocular surface. - Diagnostic staining of cornea and conjunctiva: enables visualization of epithelial defects, foreign bodies and tear‑film abnormalities. - Topical ocular anesthesia for minor procedures: provides temporary numbness for slit‑lamp examinations, foreign‑body removal, or laser treatments. - Assessment of tear‑film integrity: fluorescein staining helps evaluate dry‑eye severity and corneal health.

Adverse reactions may occur following ocular application of Lidokain-Fluorescein.

Common Side Effects: - Stinging or burning sensation at the application site. - Transient blurred vision. - Mild conjunctival hyperemia. - Temporary eyelid edema. - Mild ocular discomfort.

Serious or Rare Side Effects: - Allergic reactions including anaphylaxis. - Severe corneal toxicity or persistent epithelial defect. - Significant rise in intra‑ocular pressure. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Vision loss if severe toxicity occurs.

Before using Lidokain-Fluorescein, consider the following safety measures. - Allergy assessment: avoid in patients with known hypersensitivity to lidocaine or fluorescein. - Contact lens wear: remove lenses before application to prevent staining and irritation. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk; data are limited. - Concurrent ocular medications: avoid mixing with other ophthalmic solutions unless directed by a clinician. - Storage: Store at room temperature below 25°C: keep in the original container, protect from light and moisture.

Lidokain-Fluorescein may interact with other ophthalmic agents.

Major Interactions (Avoid): - Topical anesthetic eye drops containing preservatives: increased risk of corneal toxicity. - Systemic lidocaine‑containing products: may potentiate systemic lidocaine effects if large ocular surface area is treated.

Moderate Interactions (Monitor Closely): - Anticholinergic eye drops: may reduce fluorescein staining quality. - Beta‑blocker eye drops: monitor intra‑ocular pressure changes. - Proton pump inhibitors: no direct interaction but monitor for systemic absorption in extensive use.